CUL4A and lung carcinoma: On the contrary, lower expression of TGFBI was noted in H157 and H322 lung cancer cell lines, and up‐regulation of TIEG1 may account for increased sensitivity to gemcitabine after knockdown of Cul4A in these two cancer cell lines.